Zakład Farmakologii i Farmakologii Klinicznej, Collegium Medicum. Uniwersytet Kardynała Stefana Wyszyńskiego w Warszawie.
DEVELOPMENT AND BARRIERS IN THE IMPLEMENTATION OF MORNING AFTER PILL SUPPLIES IN THE EUROPEAN UNION Dear Stakeholders in the EU and UK, We kindly invite you to answer a few questions regarding the public provision of morning after pill levonorgestrel 1500mcg and ulipristal acetate 30mg in your country. The pharmacy profession around the world is facing a lot of systematic changes in pharmacy practices, and we are considering possible best practices from other countries. This survey will take only 5 minutes and is about answering the supply schemes of emergency hormonal contraception service delivered in EU and United Kingdom. This survey has been designed by EPhEU Employed community Pharmacists and your participation is entirely voluntary. Accepting the survey will be considered as consent to participate in the study. All information we collect will be kept strictly confidential. They will not be shared with anyone outside of our research team. By publishing or presenting the results of this study, we will not disclose any information from which you could be identified. All survey data will be stored in a locked cabinet and on a password-protected computer. After the end of the study, the data will be kept for 7 years from the last publication of the study. Then the data will be destroyed. You may not directly benefit from participating in the study. Nevertheless, your input and point of view are of great value to us. Completing the survey is considered your consent to participate in the survey. If you have any questions, please contact: Dr Piotr Merks - project coordinator phone number: +48 602 101 979, e-mail: p.merks@uksw.edu.pl We greatly appreciate your help in this study. Thank you for your time and attention and your contribution. Link: https://lnkd.in/dTcRSbmc
